Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle

The Journal of Clinical Investigation
G E NewtonJ D Parker

Abstract

The objective of this study was to evaluate the effect of muscarinic receptor modulation on basal and beta-adrenergic stimulated left ventricular function in patients with heart failure. 21 heart failure patients and 14 subjects with normal ventricular function were studied. In Protocol 1 intracoronary acetylcholine resulted in a 60+/-8% inhibition of the left ventricular +dP/dt response to intracoronary dobutamine in the normal group, and a similar 70+/-13% inhibition in the heart failure group. Acetylcholine also attenuated the dobutamine-mediated acceleration of isovolumic relaxation (Tau) in both groups. Acetylcholine alone had no effect on Tau in the normal group, while it prolonged Tau in the heart failure group. In Protocol 2 intracoronary atropine resulted in a 35+/-10% augmentation of the inotropic response to dobutamine in the normal group, versus a non-significant 12+/-15% augmentation of the dobutamine response in the heart failure group. In Protocol 3, in 6 heart failure patients, both effects of acetylcholine, the slowing of ventricular relaxation and the inhibition of beta-adrenergic responses, were reversed by the addition of atropine. Therefore, in the failing human left ventricle muscarinic stimulation has an ...Continue Reading

References

Sep 1, 1976·The Journal of Clinical Investigation·J L WeissM L Weisfeldt
May 1, 1990·The Journal of Clinical Investigation·T R PorterP K Mohanty
Dec 1, 1989·Circulation·S K VarmaM D Feldman
Jul 1, 1988·The Journal of Clinical Investigation·A M FeldmanC Van Dop
Jun 1, 1988·The Journal of Clinical Investigation·D E VatnerC J Homcy
Jan 1, 1987·Journal of Molecular and Cellular Cardiology·J W FlemingA M Watanabe
Dec 1, 1987·Circulation·M R StarlingR A Walsh
Nov 1, 1971·Circulation Research·M N Levy
Oct 14, 1971·The New England Journal of Medicine·D L EckbergE Braunwald
Oct 1, 1993·Journal of the American College of Cardiology·J S Floras
Oct 1, 1993·Journal of the American College of Cardiology·M R Bristow

❮ Previous
Next ❯

Citations

Aug 12, 1999·European Journal of Pharmacology·C GiesslerO E Brodde
Jun 12, 2003·Journal of the American College of Cardiology·John R StrattonKen Madden
Feb 7, 1998·The Journal of Clinical Investigation·O E BroddeH R Zerkowski
Jul 27, 2012·Current Cardiology Reports·John C Lopshire, Douglas P Zipes
Nov 7, 2012·European Journal of Heart Failure·Peter J Schwartz
Sep 14, 2015·JACC. Heart Failure·Neal A Chatterjee, Jagmeet P Singh
Apr 4, 2015·Heart Failure Clinics·Mark J Shen, Douglas P Zipes
Aug 16, 2016·JACC. Basic to Translational Science·Mirnela Byku, Douglas L Mann
May 24, 2014·Circulation Research·Viorel G Florea, Jay N Cohn
Jun 10, 2008·American Journal of Physiology. Heart and Circulatory Physiology·John W AdamsDaniel Connolly
Oct 11, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Susanna Mak, Gary E Newton
Jun 28, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Mark E DunlapPaul Ernsberger
Mar 17, 2012·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Susanna MakJohn D Parker
Jan 29, 1999·Physiological Reviews·B Swynghedauw
Dec 12, 2012·Journal of Molecular and Cellular Cardiology·R I HussainK A Krobert
Sep 1, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·S DheinO E Brodde
Mar 23, 2007·Biochimica Et Biophysica Acta·Natasha C SalazarHoward A Rockman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.